159 related articles for article (PubMed ID: 8067692)
1. Alterations of p53 gene in primary gastric cancer tissues.
Hong SI; Hong WS; Jang JJ; Lee DS; Cho NS; Jung ME; Kim HB; Ha GW; Park IC; Cho DS
Anticancer Res; 1994; 14(3B):1251-5. PubMed ID: 8067692
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
5. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
6. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
Zhang J; Zheng J; Fang W
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
[TBL] [Abstract][Full Text] [Related]
8. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
Tamura G; Kihana T; Nomura K; Terada M; Sugimura T; Hirohashi S
Cancer Res; 1991 Jun; 51(11):3056-8. PubMed ID: 2032245
[TBL] [Abstract][Full Text] [Related]
9. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques.
Hurlimann J; Chaubert P; Benhattar J
Mod Pathol; 1994 May; 7(4):423-8. PubMed ID: 8066070
[TBL] [Abstract][Full Text] [Related]
10. An abundance of p53 null mutations in ovarian carcinoma.
Skilling JS; Sood A; Niemann T; Lager DJ; Buller RE
Oncogene; 1996 Jul; 13(1):117-23. PubMed ID: 8700537
[TBL] [Abstract][Full Text] [Related]
11. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
12. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
13. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
14. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
[TBL] [Abstract][Full Text] [Related]
15. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
17. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer].
Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R
Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer.
Nayak BK; Baral RN; Das BR
Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549
[TBL] [Abstract][Full Text] [Related]
19. [Detection of p53 mutation using PCR-SSCP silver staining method].
Zhao W; Si J; Li K; Zhang X; Song G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
Eguchi S; Kohara N; Komuta K; Kanematsu T
Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]